Table 1.
Cancer site | ||||||
---|---|---|---|---|---|---|
Lung | Liver | Kidney | CRC | Prostate | Breast† | |
N | 266 439 | 32 571 | 62 371 | 213 274 | 357 078 | 313 482 |
Gender, % | ||||||
Men | 53.8 | 71.7 | 61.4 | 50.9 | 100 | — |
Women | 46.2 | 28.3 | 38.7 | 49.1 | — | 100 |
Age at diagnosis, % | ||||||
0–44 | 2.3 | 5.9 | 10.8 | 5.8 | 0.7 | 13.6 |
45–54 | 10.3 | 21.5 | 18.4 | 14.3 | 9.6 | 24.0 |
55–64 | 23.2 | 28.2 | 26.3 | 21.2 | 31.2 | 24.6 |
65–74 | 31.4 | 22.4 | 23.2 | 24.3 | 35.7 | 19.0 |
75–84 | 26.0 | 17.0 | 16.6 | 24.0 | 19.1 | 14.1 |
85+ | 6.9 | 5.0 | 4.7 | 10.4 | 3.8 | 4.7 |
Stage, % | ||||||
Localized | 15.1 | 40.3 | 62.3 | 39.4 | 92.8‡ | 60.3 |
Regional | 22.0 | 26.3 | 16.8 | 36.2 | —‡ | 32.7 |
Distant | 56.4 | 18.5 | 17.1 | 19.7 | 4.1 | 5.1 |
Unstaged | 6.5 | 14.8 | 3.7 | 4.7 | 3.1 | 1.9 |
Cancer-directed surgery, % | ||||||
Yes | 20.9 | 24.0 | 82.0 | 85.8 | 38.7 | 92.8 |
Radiation therapy, % | ||||||
Yes | 7.6 | 1.3 | 3.3 | 10.4 | 2.9 | 47.7 |
Race/ethnicity,% | ||||||
NHW | 78.2 | 51.8 | 71.5 | 71.6 | 70.5 | 72.7 |
NHB | 10.9 | 11.8 | 10.5 | 11.3 | 13.6 | 10.1 |
API | 5.1 | 17.6 | 4.5 | 7.0 | 4.4 | 6.8 |
AI/AN | 0.4 | 1.1 | 0.8 | 0.5 | 0.3 | 0.5 |
HISP | 5.2 | 17.4 | 12.1 | 8.9 | 8.3 | 9.4 |
Unknown | 0.2 | 0.3 | 0.6 | 0.7 | 2.8 | 0.6 |
SES, % | ||||||
Q1 (low) | 17.4 | 19.2 | 14.7 | 14.9 | 12.5 | 12.2 |
Q2 | 17.6 | 18.3 | 16.6 | 16.8 | 15.0 | 15.1 |
Q3 | 17.4 | 18.1 | 17.6 | 17.6 | 17.0 | 17.3 |
Q4 | 16.5 | 17.8 | 17.9 | 18.1 | 18.7 | 19.5 |
Q5 (high) | 14.3 | 15.0 | 18.0 | 17.9 | 22.6 | 22.7 |
Missing | 16.7 | 11.7 | 15.3 | 14.6 | 14.2 | 13.3 |
* AI/AN = American Indian/Alaska Native; API = Asian/Pacific Islander; CRC = colorectal cancer; HISP = Hispanic; NHB = non-Hispanic blacks; NHW = non-Hispanic whites; Q = quintile; SES = socioeconomic status.
† Breast cancer restricted to women.
‡ Localized, regional combined.